Understanding of genetic kidney disease has significantly increased in past five years
Compared to the most common causes of chronic kidney disease (CKD), including hypertension, diabetes mellitus and glomerular disease, genetic CKD is “quite rare,” says Shane Bobart, MD. “I think part of the reason it’s rare is because people are still getting used to there being genetic testing for it,” he says. “It’s too early to really see a big difference, but as this testing becomes more widely available, I’m sure we’ll see the actual diagnoses increase.”
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Along with five other Cleveland Clinic researchers, Dr. Bobart collaborated on a review of the current landscape of genetic CKD that was published in the International Journal of Nephrology and Renovascular Disease. With two team members in Florida and the remaining four in Ohio, “we were able to collaborate on this across campuses, something we often do with patients as well,” says Dr. Bobart. “The best part of this work is the collaboration.”
The review delves into presentation, risks and potential treatment options for genetic kidney disease, focusing on cystic kidney disease, glomerular disease with genetic associations, congenital anomalies of the kidney and urinary tract (CAKUT), autosomal dominant tubulointerstitial kidney disease (ADTKD), and inherited nephrolithiasis and nephrocalcinosis.
“Now that we understand more about these genetic causes and have more availability to test, it’s important to be aware that there are multiple genetically-related conditions that can contribute to kidney disease,” Dr. Bobart says.
Genetic analysis is making the diagnosis of genetic disorders easier than ever before, says Xiangling Wang, MD, PhD, founding director of Cleveland Clinic’s renal genetics program and a collaborator on the review. For example, to diagnose Gitelman syndrome, “we relied on multiple blood and urine studies, which often require a 24-hour urine collection,” Dr. Wang says. “Now we only need a buccal swab or blood draw for DNA collection to make the diagnosis.”
Genetic testing has also improved diagnostic accuracy. “We’ve started to realize that in some of these patients with chronic kidney disease that was attributed to age or hypertension could possibly have a genetic cause,” says Dr. Bobart. “Genetic testing is also helpful when the diagnosis is in question.”
Dr. Wang and her team’s recent 3-year review of their daily practice at Cleveland Clinic’s renal genetics clinic also supports this. They found that 69% of patients with positive genetic findings received a new diagnosis and/or had a change in their diagnosis. “Genetic testing provided early diagnosis through a familiar variant test, which made early monitoring and treatment possible to slow the progression of chronic kidney disease,” Dr. Wang says.
More accurate diagnoses lead to improved disease management, says Dr. Wang. In her renal genetics clinic review, nearly 40% of patients with positive genetic findings had a significant change in the management of their disease.
In glomerular disease, for example, genetic testing can be especially valuable with regard to immunosuppression, according to Dr. Bobart. Hereditary nephrotic syndrome, for example, often doesn’t respond to immunosuppression, so genetic analysis can save the patient exposure to this therapy. On the other hand, some genetic causes of glomerular conditions “actually require ongoing treatment with immunosuppression because otherwise they will relapse,” Dr. Bobart says.
Another benefit of genetic testing is that it pinpoints other health issues. “Patients with polycystic kidney disease might have brain aneurysms or cysts in their liver or other non-kidney issues that need to be checked,” says Dr. Bobart. “Ensuring you have a good genetic diagnosis helps in the care of these patients.”
Genetic testing can also be beneficial for transplantation purposes. For patients with genetic kidney disease, Dr. Bobart says screening family members who may be donors is important to ensure they’re not at risk. Along with donor selection, Dr. Wang notes that genetic testing results also help post-transplant management and family counseling.
Because an earlier diagnosis of inheritable disorders has the potential to positively impact patient care, the main purpose of this review is to increase clinicians’ awareness of these genetic forms of CKD, says Dr. Bobart. “I really want us all to be more aware of these conditions so we can look for the clinical clues to know when to test and to be aware of what resources are available to test and even to treat,” he says.
Genetic testing is much more affordable and accessible than it used to be, says Dr. Wang, noting that the majority of patients seen at the Cleveland Clinic renal genetics clinic are covered by insurance. “Genetic testing can improve the diagnosis and management of CKD, and I would encourage clinicians to refer their patients to a renal genetics clinic if they suspect a genetic link,” she says.
Featured image: Renal biopsy from a patient with Fabry disease, confirmed after renal biopsy with genetic testing. The biopsy showed glomeruli with “foamy” podocytes due to the accumulation of lipid material within the cytoplasm. Jones methenamine silver x600 magnification. Copyright © 2023 Sawaf et al. This work is published and licensed by Dove Medical Press Limited. The image and its description were reprinted with permission under the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/)
